)
Edge17 Apr 2026
The New York Times Company: Adapting to the Times
How The New York Times Company built on a century-long legacy of trusted journalism to navigate disruption and reshape its business model.
Viridian Therapeutics
Viridian Therapeutics (VRDN) investor relations material
Viridian Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary17 Apr, 2026
Executive summary
Annual meeting scheduled for June 2, 2026, with voting open until June 1, 2026, at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by May 19, 2026.
Meeting will be held virtually, allowing remote participation and voting.
Voting matters and shareholder proposals
Election of two Class II director nominees, Tomas Kiselak and Jennifer K. Moses, to serve until the 2029 annual meeting.
Ratification of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.
Advisory vote to approve named executive officer compensation.
Advisory vote on the frequency of future say-on-pay votes, with the board recommending an annual vote.
Provision to transact other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends all proposals, including director nominees and auditor ratification.
Nominees for Class II directors are presented for shareholder election.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Viridian Therapeutics
- Proxy covers director elections, auditor ratification, and above-target executive compensation for 2025.VRDN
Proxy filing17 Apr 2026 - Elegrobart met all key endpoints in REVEAL-1, showing rapid, significant efficacy and safety.VRDNStudy result6 Apr 2026
- Veligrotug and elegrobart deliver strong phase 3 results, driving TED and autoimmune expansion.VRDNCorporate presentation2 Apr 2026
- TED IV therapy nears approval; subQ and pipeline programs set for major milestones in 2024.VRDNLeerink Global Healthcare Conference 20269 Mar 2026
- Veligrotug and elegrobart advance as leading TED therapies, backed by strong data and market readiness.VRDNCorporate presentation9 Mar 2026
- Phase III TED readouts, streamlined treatment, and global expansion drive near-term growth.VRDNTD Cowen 46th Annual Health Care Conference4 Mar 2026
- Veligrotug nears regulatory milestones as cash reserves support robust clinical and commercial progress.VRDNQ4 202526 Feb 2026
- Phase 3 VRDN-003 trials launch in August, targeting best-in-class subcutaneous TED therapy.VRDNGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Phase III IV data expected in September, with Sub-Q program advancing and strong market positioning.VRDNJefferies 2024 Global Healthcare Conference1 Feb 2026
Next Viridian Therapeutics earnings date
Q1 20267 May, 2026
Viridian Therapeutics
Next Viridian Therapeutics earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage